Mar 9, 2016 8:30 am EST VolitionRx Schedules Full-Year 2015 Earnings Conference Call and Business Update for Friday, March 11, 2016 at 8:30am ET
Mar 9, 2016 7:00 am EST Preliminary Data Demonstrates 86% Accuracy in Detecting Idiopathic Pulmonary Fibrosis, a Fatal Lung Disease
Feb 17, 2016 7:00 am EST VolitionRx Demonstrates 75% Accuracy in Detecting Highest-Risk Pre-Cancerous Colorectal Adenomas with NuQ® Blood Test
Feb 4, 2016 7:00 am EST VolitionRx and Cancer Survivor Sean Swarner Celebrate World Cancer Day with Message of Hope for Cancer Survival Through Early Detection
Feb 2, 2016 7:00 am EST VolitionRx Initiates Prostate Cancer Study in Collaboration with the Surrey Cancer Research Institute, University of Surrey, UK
Jan 28, 2016 7:00 am EST VolitionRx Receives International ISO Certification for Quality Management System of its NuQ(R) Blood Tests
